Scleroderma: An insight into causes, pathogenesis and treatment strategies. Issue 2 (June 2019)

• Record Type: Journal Article
• Authors: Singh, Deependra; Parihar, Arun KS; Patel, Satish; Srivastava, Shikha; Diwan, Prakriti; Singh, Manju R
• Is Part Of: Pathophysiology. Volume 26:Issue 2(2019)
• Page Start: 103
• Page End: 114
• Publication Date: 2019-06
• Subjects: Scleroderma -- Autoimmune disorders -- Pathogenesis -- Oxidative stress -- Antioxidants; Physiology, Pathological -- Periodicals; 571.9
• DOI: 10.1016/j.pathophys.2019.05.003
• Languages: English
• ISSNs: 0928-4680

Abstract

Abstract: Scleroderma is an autoimmune disorder, characterized by morphological changes in skin followed by visceral organs. The pathogenesis of scleroderma involves immune imbalance and generation of auto antibodies. The major causes of scleroderma include multitude of factors such as immune imbalance, oxidative stress, genetics and environment factors. A constant effort has been made to treat scleroderma through different approaches and necessitates life time administration of drugs for maintenance of a good quality life. It has been reported more in women compared to men. Traditional treatment strategies are restricted by limited therapeutic capability due to associated side effects. Advancement in development of novel drug delivery approaches has opened a newer avenue for efficient therapy. Current review is an effort to reflect scleroderma in provisions of its pathogenesis, causative factors, and therapeutic approaches, with concern to mode of action, pharmacokinetics, marketed products, and side effects of drugs.